Lilly Wins Short Ban On Generic Strattera
A federal judge has ruled that generics makers may not launch their own versions of Eli Lilly & Co.'s Strattera in the U.S. for two weeks following the entry of a...To view the full article, register now.
Already a subscriber? Click here to view full article